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Abstract
Biopersistence of carbon nanotubes, graphene oxide (GO) and several other types of carbonaceous 
nanomaterials is an essential determinant of their health effects. Successful biodegradation is one 
of the major factors defining the life span and biological responses to nanoparticles. Here, we 
review the role and contribution of different oxidative enzymes of inflammatory cells - 
myeloperoxidase, eosinophil peroxidase, lactoperoxidase, hemoglobin, and xanthine oxidase - to 
the reactions of nanoparticle biodegradation. We further focus on interactions of nanomaterials 
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with hemoproteins dependent on the specific features of their physico-chemical and structural 
characteristics. Mechanistically, we highlight the significance of immobilized peroxidase reactive 
intermediates vs diffusible small molecule oxidants (hypochlorous and hypobromous acids) for the 
overall oxidative biodegradation process in neutrophils and eosinophils. We also accentuate the 
importance of peroxynitrite-driven pathways realized in macrophages via the engagement of 
NADPH oxidase- and NO synthase-triggered oxidative mechanisms. We consider possible 
involvement of oxidative machinery of other professional phagocytes such as microglial cells, 
myeloid-derived suppressor cells, in the context of biodegradation relevant to targeted drug 
delivery. We evaluate the importance of genetic factors and their manipulations for the enzymatic 
biodegradation in vivo. Finally, we emphasize a novel type of biodegradation realized via the 
activation of the “dormant” peroxidase activity of hemoproteins by the nano-surface. This is 
exemplified by the binding of GO to cyt c causing the unfolding and “unmasking” of the 
peroxidase activity of the latter. We conclude with the strategies leading to safe by design 
carbonaceous nanoparticles with optimized characteristics for mechanism-based targeted delivery 
and regulatable life-span of drugs in circulation.
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Introduction
Advances in the development, production and applications of nanomaterials inevitably lead 
to numerous chemical and biochemical interactions at the interfaces of biological systems 
with nanoparticles that result in a variety of responses by the former as well as modifications 
of the latter. One can imagine that during the repetitive cycles of these interactions both the 
materials and the organisms are affected resulting in alterations that may change the 
consequences and the meaning of the interfacing partners. One of the first important 
modifications of the nanoparticles in biological systems is the formation of protein-lipid 
“corona” (Monopoli et al, 2012; Kapralov et al., 2012; Tenzer et al., 2013). The composition 
and properties of “corona” are dependent on the local microenvironments in biological 
fluids, tissues and cells, thus determining the specificity of nanoparticles-evoked reactions 
(Walkey et al., 2012; Sacchetti et al., 2013; Cai et al., 2013; Treuel et al., 2015). The 
physicochemical characteristics of the corona can also undergo marked changes due to 
metabolic conversions in the body and also via chemical reactions catalyzed by active 
ingredients of nanoparticles (Gao et al., 2014; Ma et al., 2015; Docter et al., 2015). This, in 
turn, triggers strongly modified biological responses (Dutta et al., 2007; Wang et al., 2013). 
Among the constituents of the protein corona, there may be enzymes contributing to the 
biodegradation process such as peroxidases, isoforms of CYP450, lysosomal hydrolases, etc.
Overall, nanoparticles tend to either be readily degradable or resistant to degradation in 
terms of their sensitivity to biodegradation. The first group includes nano-liposomes and 
polymeric nano-arrangements (such as dendrimers, micelles) (Kamaly et al., 2012; Xie et 
al., 2014; Chuan et al., 2015). Effective degradation of these nanomaterials is particularly 
important in the context of drug delivery aimed at the achievement of the prolonged 
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circulation of the nano-vehicle with the payload (Owens et al., 2006; Loos et al., 2014; 
Pérez-Herrero et al., 2015). The second group comprises carbon-based nanoparticles with 
sp2 hybridization of carbon atoms (i.e. carbon nanotubes, nanohorns and graphene family 
materials) (Kotchey et al., 2013a; Zhang et al., 2014a). These nanomaterials are more 
persistent and can either display prolonged life-time at the sites of their entry or migrate to 
distant locations (Liu et al., 2008; Yang et al., 2008; Shvedova et al., 2012a, 2014). The 
mechanisms underlying the resistance of the latter type of nanoparticles to biodegradation 
are important not only for their biomedical applications but also in regards to unintended 
exposures in occupational and environmental settings.
While studies of nanoparticles degradation have been conducted essentially from the time of 
their discovery and initial applications (mostly in the field of anticancer therapy (McDevitt 
et al., 2007; Liu et al., 2009; Burke et al., 2009; Liang and Chen, 2010)), the discovery of in 
vivo biodegradation of carbonaceous nanomaterials by enzymatic machinery of 
inflammatory cells (Kagan et al., 2010; Shvedova et al., 2012a) and enhancement of the 
enzymatic degradation of carbon nanotubes by surface modification caused a new wave of 
interest to this issue (Ali-Boucetta and Kostarelos, 2013; Orecchioni et al., 2014; 
Sureshbabu et al., 2015). This was mostly driven by exploration of new approaches to 
regulate the life-time of nanoparticles in desirable ways: increasing the circulation time of 
drug nano-carriers and enhancing the biodegradation process of nanomaterials causing 
inflammatory responses and toxicity after inadvertent exposures (Liu et al., 2010; Sacchetti 
et al., 2013; Shvedova et al., 2012b). Notably, a variety of microbial biodegradation 
enzymatic mechanisms have been described with the emphasis on their potential role in 
biodegradation of environmental nanoparticles (Zhang et al., 2013).
Enzymatic oxidative degradation of carbonaceous nanoparticles
The chemical oxidative degradation of pristine carbonaceous materials using strong acids 
and oxidants (such as mixtures of sulfuric acid and hydrogen peroxide, different chemical 
generators of hydroxyl radicals) has been known for quite some time (Liu et al., 1998; 
Zhang et al., 2003; Allen et al., 2009). However, the biological relevance of these oxidative 
processes remained elusive in spite of the fact that the catabolic pathways for oxidative 
degradation of different organic molecules in the body (e.g., by different P450 isoforms) 
have been well characterized (Hrycay and Bandiera, 2015; Olsen et al., 2015). One of the 
first indications that biologically relevant peroxidase reactions may be responsible for 
degradation of nanomaterials came from experiments with single-walled carbon nanotubes 
(SWCNTs) by a plant enzyme, horseradish peroxidase (HRP) (Allen et al., 2008). 
Subsequent detailed studies of the mechanisms and the reaction products (Allen et al., 2009; 
Zhao et al., 2011) demonstrated that other bio-peroxidases, particularly those present in 
inflammatory cells, can also effectively oxidatively “metabolize” carbonaceous 
nanomaterials (Kagan et al., 2010; Kotchey et al., 2012). Indeed, a number of different 
oxidative enzymes have been tested and found effective as a mechanism of nanoparticle 
biodegradation (Kotchey et al., 2013a). The list of enzymes includes myeloperoxidase 
(MPO), eosinophil peroxidase (EPO), lactoperoxidase, hemoglobin and xanthine oxidase 
(Table 1). Contrary to HRP, another plant metallo-enzyme Mn peroxidase, was shown to 
degrade pristine but not carboxylated SWCNTs (Zhang et al., 2014b). These studies also 
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established that two types of reactive intermediates – those formed within the protein 
(particularly oxo-ferryl iron (Fe4+=O) of heme-peroxidases (Compound I)) as well as freely 
diffusable low molecular weight oxidants such as hypochlorous and hypobromous acids 
(HOCl and HOBr) – can be responsible for the oxidative modification of carbonaceous 
nanomaterials, (Table 2) (Sutherland et al., 1993; Kagan et al., 2010; Vlasova et al., 2011). 
The relative contribution of these two types of oxidants to the overall degradation process 
may vary dependently on the type of enzyme, conditions (particularly pH), pro-/anti-
inflammatory status, etc (Kotchey et al., 2013b; Vlasova et al., 2012). In all cases, however, 
the presence of catalytic metals is necessary for triggering the degradation process.
Numerous studies emphasized the effects of diversified organic compounds, particularly 
hydrophobic molecules, with the expression of different isoforms of CYP450 and their 
activity (reviewed in Zanger and Schwab, 2013; Hrycay and Bandiera, 2015). Moreover, 
particular carbonaceous materials can also cause robust changes in the functions of CYP450 
system (Ji et al., 2009; Fröhlich et al., 2010; Che Abdullah et al, 2014; etc.). This catalytic 
responsiveness of CYP450 has lead to the development and applications of carbonaceous 
nanoparticles complexes with these hemoproteins as CNT-conjugated P450-biosensors 
(Pauwels et al., 2010; Carrara et al., 2011; Baj-Rossi et al., 2012).
Surprisingly, to the best of our knowledge there have been no studies demonstrating the 
propensity of CYP450 to biodegrade nanoparticles. This may represent an interesting 
direction of research because highly reactive Compound I is generated during P450 
catalyzed metabolism of xenobiotics or direct interaction of these hemoproteins with H2O2 
or organic hydroperoxides (peroxidase shunt) (Table 1) (Krest et al., 2013; Shoji and 
Watanabe, 2014).
In contrast to highly likely and straightforward capacities of CYP450 to be involved in the 
degradation of carbonaceous nanoparticles, the potential role of catalase is less obvious. In 
contrast to widely opened and solvent exposed active sites, characteristic of most 
hemoprotein-based peroxidases, the heme of catalases is deeply buried into the protein 
structure and connected with the surface via a very long and narrow access channel 
(Vidossich et al., 2012). Catalase compound I is accessible only for very small molecules to 
effectively fulfill the function of oxoferryl iron to either oxidize H2O2 or one of the aromatic 
residues of the protein thus leading to the formation of tyrosyl of tryptophanyl radicals 
(Kirkman and Gaetani, 2007; Alfonso-Prieto et al., 2012). The peroxidase activity of native 
catalase is relatively low. It is possible, however, that catalase monomers formed upon 
dissociation of multi-meric protein and/or their structural re-arrangements on the surface of 
nano-materials that will lead to the heme exposure and appearance of peroxidase-like 
activity with a typical catalytic competence to oxidize phenolic compounds (Horozova et al., 
1998). Interestingly, this type of peroxidase activity of catalase has been explored in 
reactions of controllable degradation of C3N4 to obtain biocompartible fluorescent N-C dots 
(Liu et al., 2014).
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Pseudo-peroxidase degradation by adventitious transition metals present 
in nanomaterials
The production of carbonaceous nanomaterials is often associated with the employment of 
significant amounts of transition metal catalysts, including iron, copper, manganese, etc 
(Laurent et al., 1998; Panish et al., 2013). The presence of these metals should be inevitably 
associated with the pseudo-peroxidase function inherent to nano-materials. Moreover, 
electron donor-acceptor specificity of nano-environments may be conducive to the unusual 
peroxidase-like activities of metals not traditionally associated with redox catalysis such as 
gold, silver, etc (Garg et al., 2015; Tao et al., 2013). Indeed, many studies have documented 
the peroxidase-like activities of a variety of metal-containing nanoparticles inherent to their 
structure or present as adventitious metals (Gao et al., 2014; Kagan et al., 2006a). Intrinsic 
catalytic activity of graphene oxide (GO) may be associated with its paramagnetic properties 
(Song et al., 2010; Su et al., 2012; Garg et al., 2015). As an illustration, we present EPR 
spectra of GO samples demonstrating the presence of Mn(II) inclusions with paramagnetic 
propensities and narrow paramagnetic signal of GO structure (Fig. 1A). Notably, the Mn-
containing GO samples displayed peroxidase-like activity as revealed by their ability to 
oxidize typical peroxidase substrates Amplex Red and dichlorofluorescein (DCFH) (Fig. 
1B). This type of peroxidase activities associated with integrated or adventitious metals in 
nanoparticles can act as an important biodegradation factor. It may act as a self-propelled 
biodegradation mechanism, including one that may be intentionally built-in as a self-
biodegradation factor.
Awakening of dormant peroxidase activity during interactions of 
hemoproteins with nano-surfaces
Specific interactions of nanomaterials with hemoproteins that can trigger the conversion of 
hexa- to penta-coordinated states of the heme iron in “dormant” peroxidases are of particular 
interest in the context of biodegradation (Kagan et al., 2004; Kapralov 2007). As a typical 
example, one can consider interactions of cytochrome c (cyt c), the hexa-coordinated 
hemoprotein in the intermembrane space of mitochondria, with GO. The negative charges 
on GO’s surface favor binding to basic proteins such as cyt c that has eight positive charges 
on its surface (Fig. 2) (Koppenol et al., 1982; Yang et al., 2013). Extensive previous work 
established a very peculiar behavior of cyt c upon its interactions with negatively charged 
phospholipids, particularly, cardiolipin, a unique doubly-charged phospholipid of 
mitochondria (Kagan et al. 2005; Kapralov et al., 2011). During this interaction, the protein 
undergoes structural rearrangements leading to its conversion from the hexa-coordinated to 
the penta-coordinated electron configuration resulting in “unmasking” of its peroxidase 
activity (Vlasova et al., 2006). This phenomenon has been extensively studied in 
mitochondria, cells, and tissues and its role in the execution of apoptotic cell death program 
and consequences for tissue damage have been well established (Kagan et al., 2006b; 
Hüttemann et al., 2011). Notably, these specific interactions of hemoproteins with nano-
surfaces are meaningful in the context of degradation of nanomaterials. The schema of these 
interactions and several sets of experimental data illustrate the pathways and significance of 
GO binding of cyt c resulting in unfolding of the protein, weakening of the heme iron/Met80 
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sulfur bond and low to high spin transition leading to peroxidase activation (Fig.3). The 
respective transitions of cyt c can be characterized by spectral changes (Figs. 4A, 4B) (Jiang 
et al., 2014). Accordingly, cyt c displays significant peroxidase activity upon its binding to 
the GO surface (Fig. 5) (Yang et al., 2013; Hua et al., 2012). Most importantly, the 
peroxidase reactive intermediates of cyt c can directly oxidize GO causing its degradation 
detectable by visible-NIR spectroscopy, TEM and XPS (Fig. 6 and Table 3). Thus, by 
unfolding and activating cyt c into a peroxidase, GO inflicts self-degradation. It is likely that 
cyt c/GO interactions represent a prototypical example of a very interesting new type of 
biodegradation reactions triggered by interactions of different hemoproteins with charged 
nano-surfaces. This new type of biodegradation reaction may lead to the design and 
development of new generations of nano-platforms for drug delivery as well as for 
modulating the physicochemical characteristics of nanomaterials. Indeed, oxidative 
modifications of GO have been associated with the changes of its conducting-
semiconducting characteristics (Kotchey et al., 2011). In this regard, the entire family of 
globins, particularly a recently discovered cytoglobin (Kawada et al., 2001; Beckerson et al., 
2015), can represent a promising instrument for the controlled and targeted modification/
degrade action of carbonaceous nanomaterials (Ascenzi et al., 2013).
Alternatives (non-peroxidase) to enzymatic oxidative degradation of 
nanomaterials
In addition to peroxidase-based mechanisms, other oxidative metabolic reactions may 
contribute to the biodegradation process. Among the physiologically relevant mechanisms, 
peroxynitrite generating reactions have been identified as potent mechanisms of nanoparticle 
biodegradation (Kagan et al., 2014). Oxidative biodegradation of SWCNTs via 
superoxide/NO• → peroxynitrite-driven pathways of activated macrophages facilitate 
clearance of nanoparticles from the lung. This particular pathway includes two enzymatic 
components producing NO• and superoxide radicals, respectively – iNOS and NADPH 
oxidase. Interestingly, another generator of superoxide radicals, xanthine oxidase, can also 
contribute to degradation of oxidized multi-walled carbon nanotubes (ox-MWCNTs) (Table 
1) (Sureshbabu et al., 2015).
Oxidative degradation of nanoparticles by inflammatory cells
Among many encounters with the gateway cells of the body, interactions of nanoparticles 
with immune/inflammatory cells are of particular interest for at least two reasons. 
Inflammatory cells are “armed” with different types of generators of reactive oxygen and 
nitrogen species (ROS and RNS, respectively) as well as hypochlorous acid. These chemical 
agents have strong oxidizing redox potentials enabling their reactivity towards the 
carbonaceous surface of nanoparticles (Sutherland et al., 1993; Davies et al., 2008) (Table 
2). Notably, oxygenation (along with nitration, chlorination) of the lipid-protein “corona” of 
nanoparticles generates clusters of hydrophilic and/or negatively charged functionalities 
recognizable by inflammatory cell receptors, thus triggering a vicious cycle of interactions 
leading to a severe inflammatory response (Konduru et al., 2009; Shvedova et al., 2005, 
2012b). In professional phagocytes, the major events include engulfment, uptake, possible 
intracellular metabolism, and digestion (Nauseef, 2007; Dale et al., 2008; Elgrabli et al., 
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2008). Two major factors – enzymatic machinery generating reactive intermediates and a 
source of oxidizing equivalents (e.g., H2O2, lipid hydroperoxides) – are required for the 
effective degradation of carbonaceous nanomaterials. While oxidative enzymes are always 
constitutively expressed in certain types of immune cells, the levels of their expression may 
be increased many-fold by pro-inflammatory conditions (Brüne et al, 2013; Mangge et al., 
2014), including those triggered by the nanoparticles (Lee et al., 2012; Bussy et al., 2012).
Neutrophils are the first line of responders to pro-inflammatory stimulation and their 
`response reaction includes the activation of MPO-driven pathways. In the context of 
biodegradation, two mechanisms – immobilized reactive intermediates of the protein itself 
and highly diffusible small molecule oxidants such as hypochlorous acid HOCl – have been 
identified as components of the oxidative process (Nauseef et al., 2007, Arnhold and 
Flemmig, 2010). The role and contribution of these two factors into the overall degradation 
may depend on the specific conditions (e.g., the presence of sufficient amounts of Cl− ions) 
in the microenvironment. In vitro, activation of neutrophils (by fMLP and cytochalasin B or 
by serum opsonized zymosan) is required to achieve significant levels of oxidative 
biodegradation (Kagan et al., 2010; Lu et al., 2014). Normally occurring opsonization of 
particles in the body –stimulating their uptake by phagocytes - can be mimicked by their 
functionalization with immunoglobulins to facilitate the particles’ uptake by neutrophils. 
Under these conditions, neutrophils respond by oxidative burst detectable by the generation 
of superoxide anion radicals which dismutate to yield H2O2. The latter is required to feed 
the peroxidase reaction of MPO, thus causing oxidative biodegradation of nanoparticles. The 
efficiency of this pathway has been documented for SWCNTs (including their PEGylated 
forms) and GO (Kagan et al., 2010; Bhattacharya et al., 2014; Kurapati et al., 2015). Not 
only active MPO but also sufficiently high activity of NADPH oxidase – generating 
superoxide radicals - is necessary to maintain the degradation process. The essentiality of 
this function of NADPH oxidase has been demonstrated both pharmacologically (using its 
inhibitors) as well as genetically (using NADPH oxidase deficient animals (Shvedova et al., 
2008; Kagan et al., 2014)).
Eosinophils another class of immune cells - combat multicellular parasitic organisms 
engaging a specialized peroxidase, EPO, capable of generating hypobromous acid (HOBr) 
and low levels of hypochlorous acid at acidic pH (Davies 2008). In murine eosinophils 
activated by cytochalasin B plus platelet-activating factor (PAF), the oxidizing enzyme, 
EPO, is released to cause extracellular degradation of SWCNTs (Andón et al., 2013).
Macrophages employ the complex of reactions leading to the production of peroxynitrite, 
another potent oxidant capable of oxidative degradation of carbonaceous nanomaterials. 
Two enzymatic systems - NADPH oxidase and NO synthase - produce superoxide radicals 
and NO•, respectively. Both of these molecules are not reactive enough to oxidatively 
biodegrade nanoparticles. However, O2−• and NO• can effectively react to yield 
peroxynitrite, whose oxidizing potency is sufficient to cause biodegradation (Ischiropoulos 
et al., 1992). In vitro, effective biodegradation capacity has been demonstrated for several 
types of macrophages such as RAW 264.7, THP-1, and human monocyte-derived 
macrophages (Kagan et al., 2014; Elgrabli et al., 2008, 2015; Zhang et al., 2015) (Table 1). 
Because peroxynitrite-dependent oxidation reactions are independent of the direct binding of 
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the reactive protein intermediates with nanoparticles, the degradation process driven by 
macrophages is independent on the specific positioning of the oxidative machinery on the 
surface of nanoparticles. As a result, different types of nanomaterials – oxidatively pre-
modified as well as pristine - may undergo degradation by macrophages. It is also possible 
that macrophages “prime” the nano-objects to generate “oxidized” sites where released 
enzymes of neutrophils and eosinophils can selectively “land” to propagate the process 
initiated by macrophages.
It is possible that other types of immune cells – specific to particular organs and/or disease 
conditions – may be involved in biodegradation of carbonaceous nanomaterials. For 
example, microglial cells in the brain can act similar to macrophages and catalyze the 
reactions leading to peroxynitrite and ROS formation, hence effectively biodegrading 
nanoparticles (Goode et al., 2015; Bussy et al., 2016). The evidence for the occurrence and 
effectiveness of this pathway in the brain is accumulating (Nunes et al., 2012). Another 
example is myeloid-derived suppressor cells (MDSC) – a heterogenous population of 
immature cells from the myeloid lineage. As a result of an altered hematopoiesis, amounts 
of MDSCs can be highly increased in severe disease conditions, particularly chronic 
infections and cancer (Gabrilovich et al., 2012). These pathological conditions lead to over-
expression of NADPH oxidase, iNOS and MPO in MDSC creating a highly pro-oxidant 
intracellular environment (Youn et al., 2012). These specific features of MDSC may be 
exploited for the targeted degradation of nanomaterials for optimized delivery of drugs 
(Zhao et al., 2015). MDSC-derived oxidants can open carbon nano-cups (NCNCs) loaded 
with antitumor drug paclitaxel and corked with gold nanoparticles (GNPs) and release 
paclitaxel (Figs. 7, 8).
Biodegradation of nanomaterials by inflammatory cells in vivo : role in 
pulmonary inflammation and fibrosis
There is a common opinion about biopersistence of nanoparticles in the body. While 
extended circulation of drug nano-carriers with payloads may be desirable, the ineffective 
elimination of nanoparticles from the organs after unintentional exposure or as a result of 
therapeutic attempts seems to represent a serious problem. Poorly degradable nanomaterials 
can accumulate in organs and inside cells where they can cause detrimental effects (Fig. 9). 
Even with regards to carbonaceous nanomaterials that are readily susceptible to 
biodegradation, carbon nanotubes may remain inside macrophages in the spleen and liver for 
prolonged periods of time following parenteral administration (Yang et al., 2008, Clichici et 
al., 2014; Albini et al., 2015). Moreover, SWCNTs have been observed in the lungs of 
exposed mice up to one year after pharyngeal administration (Shvedova et al., 2014). 
Overall, however, high-aspect, bulky carbonaceous nanomaterials tend to have longer 
retention times within the tissues and are less effectively cleared than short functionalized 
particles that are readily taken up and degraded by phagocytes (Mercer et al., 2008; Murphy 
et al., 2011, Bussy et al., 2012). Notoriously, the appearance of nanoparticles in tissues 
triggers robust inflammatory responses. Given that immune cells can spend some of their 
pro-oxidant potential on biodegradation of the nanoparticles, and thus display a weakened 
immune response, studies of nanoparticle biodegradation in vivo and possible regulation of 
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biodegradation in the context of inflammation in vivo became necessary (Shvedova et al., 
2007; Kotchey et al., 2013b; Dumortier et al., 2013). These issues have also stimulated the 
concepts of creating safe-by-design nanoparticles as well as employment of inflammatory 
cells for targeted drug delivery (Sureshbabu et al., 2015; Zhao et al., 2015).
In line with the ability to take up and biodegrade carbonaceous nanomaterials, professional 
phagocytes are believed to be mostly accountable for the clearance of the engulfed 
nanoparticles in vivo. Several studies established the association between the clearance of 
carbonaceous nanoparticles in the lungs and the amounts of neutrophils and macrophages in 
the respective tissues (Shvedova et al., 2005, 2012a). These correlational relationships imply 
that, indeed, biodegradation reactions taking place in inflammatory cells are substantial 
contributors to the overall elimination of nanoparticles from the tissues. In support of this 
conclusion, the data on the time course of inflammatory responses and SWCNTs elimination 
in mice with k/o MPO clearly demonstrated the dependence of these biomarkers on the 
genetic manipulations with the major biodegrading oxidative enzyme of neutrophils, MPO. 
Quantitative imaging clearly demonstrated the link between MPO-catalyzed degradation of 
nanoparticles and one of the hallmarks of the inflammation – pulmonary fibrosis – in wild 
type (WT) versus MPO k/o animals (Shvedova et al., 2012a). The role of NADPH oxidase 
as a supplier of superoxide for the subsequent reactions of dismutation (to generate H2O2 as 
a fuel for MPO) or with NO• (to produce peroxynitrite in macrophages) has been revealed in 
experiments with genetically manipulated animals. Clearance of SWCNTs was 10-fold less 
effective in NADPH oxidase-deficient mice (gp91phox(−/−) mice) vs WT animals. 
Photoacoustic imaging also documented significantly reduced rate of SWCNTs clearance in 
the lung of NADPH-deficient mice compared to WT control animals (Kagan et al., 2014). 
There are clear experimental indications that microglial cells - with their highly developed 
oxidative enzymatic machinery similar to that in macrophages – are primarily responsible 
for the biodegradative elimination of MWCNTs from the brain (Nunes et al., 2012; Bardi et 
al., 2013; Bussy et al., 2016).
Employment of enzymatic biodegradation of nano-containers for targeting 
inflammatory cells in cancer. Peroxidase degradation of payloads vs nano-
containers – significance for drug delivery
Design and development of nano-platform based carriers for drug delivery represents one of 
the active fields for biomedical applications (Battigelli et al., 2013). In this context, effective 
timely degradation of drug carriers becomes particularly important but must be optimized 
with regards to nano-carrier vs drug payload degradation (Farokhzad et al., 2006). It has 
been well documented that oxidative enzymes of inflammatory cells, particularly MPO, can 
catalytically destroy different types of small organic molecules, including drugs, in 
circulation (Davies 2008). This wasteful drug metabolism may be exceptionally strong in 
pro-inflammatory conditions associated with increased amounts and activation of 
inflammatory cells. This raises the question of possible “protective” role of nano-carriers in 
preventing unnecessary degradation of payloads and preservation of their therapeutic 
potential. Notably, experimental assessments of nano-carrier vs drug degradation have not 
been adequately addressed. A recent study compared degradation of an antitumor drug, 
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doxorubicin (DOX), in free form vs its conjugate with SWCNTs in the presence of MPO or 
ONOO-generating systems (Seo et al., 2015). The evaluations in simple biochemical 
enzymatic systems clearly demonstrated that the SWCNTs-associated drug molecules 
(DOX-SWCNTs) degraded more slowly than free DOX. Notably, cytostatic and cytotoxic 
effects of free DOX, but not nanotube-carried drug, on melanoma and lung carcinoma cell 
lines were abolished in the presence of tumor-activated MDSC known to express high levels 
of MPO, NADPH oxidase and iNOS thus providing enhanced myeloperoxidase- and 
peroxynitrite-induced conditions for biodegradation of organic molecules. Optimizing the 
balance between the degradation and resistance of the drug carrier and the payload towards 
the oxidants generated by inflammatory cells is critical to meet the needs for safety and 
prolonged circulation while orchestrating the stability and therapeutic effect of the drug. 
This strategy opens opportunities for exploring new parameters in biodegradation and 
developing controllable degradation properties by chemical modification of the surface of 
nanotubes. Further studies are necessary to elucidate important details relevant to the 
degradation characteristics of different drug nano-delivery systems in the context of 
achieving their optimized therapeutic potential.
Concluding remarks
The currently accelerating progress in nanotechnologies has already accepted the “safe-by-
design” principle as a necessary requisite in the development of new nanomaterials. This 
principle has to include the “safe-by-biodegradation” component, providing for the 
optimized life-time and clearance of nanoparticles from the body. In this context, the broad 
applications of nitrogen-doped carbon nanomaterials offer a very important advantage in 
creating defects in the structure that can serve as “biodegradation” initiation centers. The 
introduction of principally new nanomaterials with unexpected features of their interactions 
with the intracellular mechanisms of genetic, epigenetic, and metabolomics regulation calls 
for new approaches to assessments of their toxic mechanisms. For example, a recently 
introduced spherical nucleic acids (Service, 2015) – nano-DNA arrays that can readily enter 
the cells, “seeks and binds” very low quantities of complementary DNA and RNA from 
pathogenic bacteria and viruses in the blood. As this affects the expression of selected genes, 
the resourcefulness in evaluating potential side effects, toxicity, and clearance become 
particularly important. New generations of nano-platforms are designed and used not only as 
effective delivery vehicles but also for the engagement of their unique nano-characteristics 
in manipulations of cell metabolism, cell-cell communications, and pathogen-host 
interactions. Oxidative modifications of these innovative materials by immune cells may 
result in the emergence of unforeseen propensities and, consequently, unexpected effects on 
cell functions. Exploration and utilization of targeted, enzymatically-catalyzed, oxidative 
modification/biodegradation of these new nanomaterials represent an exciting future area of 
research.
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Nanoparticles can be degraded by oxidative enzymatic machinery of inflammatory cells.
Peroxidase-generated oxidants are the reactive species executing the biodegradation.
Unmasked by GO binding peroxidase activity of cyt biodegrades GO.
Professional phagocytes are accountable for the clearance of nanoparticles in vivo.
Carbonaceous nano-carriers of drugs protect against degradation of payloads.
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Fig. 1. Paramagnetic properties of GO are accountable for its peroxidase-like activity
A) – EPR spectrum of GO measured at 77K is a composition of a narrow EPR spectrum at 
g~2.0 which is due to intrinsic paramagnetic properties of GO and hexa-component EPR 
spectrum of manganese embedded into carbon structure.
B) – GO can oxidize peroxidase substrates characterized by low reduction potentials: 
Amplex red, dichlorofluorescein (DCFH), and ascorbate (n=3). H2O2 (100 µM) was added 
to the solutions of substrates (50 µM) and GO (0.1 mg/ml) and formation of fluorescent 
products was detected at 30 or 60 min. In the absence of GO fluorescence responses from 
Amplex red or DCFH were lower than 10 A.U. EPR signal of ascorbate (1 mM) could be 
measured in the absence of H2O2 but not in the absence of GO (0.5 mg/ml).
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AFM evidence for cyt c binding with GO. 5 µM cyt c were added to a suspension of GO (0.2 
mg/ml) in 20 mM Na-phosphate buffer, pH 7.4 and tapping mode AFM height analysis was 
performed. Average GO height is 1.5 nm, and height of cyt c ranges from 3.3 to 3.7 nm.
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Cyt c binding and peroxidase activation upon interaction with GO. Eight positive charges on 
the surface of cyt c (Lys+) can electrostatically interact with the negatively charged oxygen-
containing functional groups of GO. This interaction of cyt c with GO leads to protein 
unfolding associated with the “awakening” of dormant peroxidase activity. This peroxidase 
activation of cyt c can trigger – in the presence of oxidizing equivalents (H2O2, organic 
hydroperoxides) -oxidative modification/degradation of GO.
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Fig. 4. Absorption spectra of cyt c illustrating GO-induced formation of high-spin form of heme-
iron and weakening of the heme iron/Met80 sulfur bond
A) - Effect of GO on the formation of high-spin iron state of the hemoprotein. a) - Optical 
absorption spectra of cyt c in the absence (solid line) and in the presence (dashed line) of 
GO; b) - differential absorption spectrum (obtained by subtracting spectrum of cyt c from 
spectrum of cyt c incubated with GO) shows positive features at 480–495 and 610–625 nm 
accompanied by a clear trough at 700 nm indicative of high-spin ferric heme; c) Effect of 
GO on the height of a peak at 480 nm (75 µM cyt c, n=3).
B) - Dependence of the absorbance of the Fe-S(Met80) bond (λ 695 nm) on GO/cyt c ratio. 
Characteristic absorbance band at 695 nm is associated with an axial coordination of the 
heme iron by the sulfur atom of Met80 in cyt c active site. In the presence of GO, loss of 
absorbance band at 695 nm was observed indicating the disruption or weakening of the Fe-
S(Met80) coordination. Insert - optical absorption spectrum of cyt c at region around 695 nm 
before and after subtracting of baseline. The absorbance was measured in 20 mM HEPES 
buffer containing 100 µM DTPA (pH 7.4) using 50 µM of cyt c, n=7-9.
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Fig. 5. Binding of GO to cyt c causes unfolding of the protein and increases the accessibility of 
cyt c active site
A) - GO facilitates cyt c nitrosylation as evidenced by low temperature EPR spectroscopy. 
Magnitude of the signal of nitrosylated cyt c depends on GO/cyt c ratio revealing the 
increase of the accessibility of cyt c active site towards nitric oxide upon enzyme binding to 
GO (Vlasova et al., 2006). Inserts are EPR spectra of cyt c nitrosylated in the absence (blue) 
and in the presence (red) of GO. EPR spectrum of nitrosylated cyt c/GO complexes includes 
pronounced narrow GO spectrum at g~2. Reduced cyt c (100 µM, 500 µM ascorbate) was 
incubated with GO at 37°C for 5 min in 50 mM sodium phosphate buffer, pH 7.4, 
containing 100 µM DTPA, then 750 µM PAPANONOate was added and incubation was 
continued for additional 15 min. The reaction was stopped by freezing the samples in liquid 
nitrogen. EPR spectra of nitrosylated cyt c were measured at 77K.
Binding to GO confers peroxidase activity on cyt c: B) - Magnitude of EPR spectrum of 
etoposide-phenoxyl radicals (insert) generated in the peroxidase reaction of cyt c/GO 
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complexes in 2 min after addition of 100 µM H2O2 (7.5 µM cyt c) (Kagan et al., 1999); C) - 
Oxidation of peroxidase substrate ABTS by cyt c/GO. Oxidation of ABTS to yield the 
product with absorbance maximum at 410 nm was performed at reagent concentrations: 5 
µM cyt c, 1 mM ABTS and 100 µM H2O2. The effect of GO on cyt c peroxidase activity is 
compared to the effects of TOCL (blue bar) and ox-SWCNTs.
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Activation of cyt c into peroxidase caused biodegradation of GO. GO (100 µg/ml) was 
suspended in 50 mM Na-phosphate buffer, containing 100 µM DTPA, pH 7.4. Cyt c (2.5 
µM) was added once a day and micro aliquotes of H2O2 (50 µM after each addition) were 
added 5 times a day during 5 days. a) - Visual evidence of GO degradation as a result of 
treatment with cyt c and H2O2 (sample 2). Pictures of GO samples were taken in 6 days of 
incubation; b) -optical absorbance of the sonicated samples at 1100 nm. For each sample, 
data are averaged for three independent suspensions, * p<0.05 versus control. c) - TEM 
images of untreated GO (control), GO incubated with H2O2, and GO treated with cyt c and 
H2O2.
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Transmission electron microscopy (TEM) images of nitrogen-doped carbon nanotube cups 
(NCNCs). A) NCNCs synthesized from chemical vapor deposition; B) NCNCs after 
separation through probe-tip sonication; C) separated NCNCs loaded with paclitaxel and 
corked with gold nanoparticles (GNPs) through citrate reduction of chloroauric acid; D) 
GNP corked NCNCs after incubation with myeloid-derived suppressor cells (MDSC), 
removal of the GNP cork and degradation of nanotube sidewalls is demonstrated in addition 
to release of loaded cargo. All scale bars are 100 nm.
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Nitrogen-doped carbon nanotube cups (NCNC) loaded with paclitaxel (Pac) block TGF-β 
production by tumor-associated MDSC. Bone marrow MDSC were sorted from tumor-free 
and B16-bearing mice (3 weeks), incubated with medium (Control), empty NCNC and 
NCNC/Pac. TGF-β was measured by ELISA. *, p<0.05 (vs controls in tumor-free mice; **, 
p<0.05 (vs NCNC Pac).
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Hyperspectral images (CytoViva) of the lung tissue of mice at day 7 after pharyngeal 
aspiration of SWCNTs. The scanned images a) were collected at 40 × employing an 
Olympus BX-51 microscope and a 100 W quartz-halogen light source. The pixels that match 
the SWCNTs spectral profiles were mapped in red b). Spectral data c) was captured with the 
CytoViva spectrophotometer utilizing an integrated CCD camera.
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Table 1
Enzymatic degradation of carbonaceous nanomaterials with sp2 hybridization by in vivo relevant oxidative 
systems.










Kagan et al., 2010;
Vlasova et al., 2012;
HOCl, HOBr PEG-SWCNTs Bhattacharya et al.,2014
Nitrogen-doped CNT
cups Zhao et al., 2014
Graphene oxide Kurapati et al., 2015









ox-SWCNTs and Vlasova et al., 2011, 2012
HOBr, HOSCN ox-SWCNTs+lungsurfactant Bhattacharya et al., 2015
Xanthine oxidase + NO
(without H2O2) ONOO c-SWCNTs Kagan et al., 2014
Xanthine oxidase ox-MWCNTs, f-MWCNTs
Hemoglobin O2•− + H2O2 → HO• Sureshbabu et al., 2015
Tyr-O•, HOO•, HO• c-SWCNTs, PEG-SWCNTs





Russier et al., 2010
Murine bronchoalveolar
lavage fluid + H2O2 +
NaSCN
LPO, MPO, HOSCN ox-SWCNTs Bhattacharya et. al., 2015
Neutrophil extracellular
traps + H2O2 + NaBr
MPO, HOCl, HOBr ox-SWCNTs Farrera et al., 2014
Human neutrophils
+ fMLP and cytochalasin B







Kagan et al., 2010;
Bhattacharya et al., 2014
Macrophages: ROS, ONOO- Lu et al., 2014
Human monocyte-derived c-SWCNTs+IgG
THP-1 c-SWCNTs
THP-1 MWCNTs-NH2 Kagan et al., 2010
RAW 264.7, THP-1 Carbon nanohorns Kagan et al., 2014
Elgrabli et al., 2015
Murine eosnophils
+ cytochalasin B and PAF EPO, HOBr ox-SWCNTs Zhang et al., 2015
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suppressor cells MPO, HOCl
Nitrogen-doped CNT
cups Andón et al., 2013
Primary microglia n.d. (ROS, RNS) ox-MWCNTs, MWCNT- Zhao et al., 2014
Experimental animals NH2,
-Pharyngeal aspiration ox-MWCNT-NH2 Bussy et al., 2016
w/t and MPO k/o mice
-Pharyngeal aspiration MPO, HOCl c-SWCNTs
w/t and NADPH-oxidase-
deficient mice ONOO- c-SWCNTs Shvedova et al, 2012
-Stereotactic
administration Kagan et al, 2014
C57BL/6 mice (ROS) MWCNT-NH3+
Nunes et al., 2012
ROS – reactive oxygen species; RNS – reactive nitrogen species; n.d. – not determined.













Vlasova et al. Page 32
Table 2
Standard reduction potentials for redox couples of oxidants which are capable to oxidize and degrade 






Compound I/compound II 1.35 Furtmuller et al., 2003
Compound II/ferric enzyme 0.97 Furtmuller et al., 2003
Eosinophyl peroxidase n.d.
Lactoperoxidase:
Compound I/compound II 1.14 Furtmuller et al., 2005
Compound II/ferric enzyme 1.04 Furtmuller et al., 2005
Cytochrome P450
Compound I/Compound II 1.35 Koppenol, 2007
HO•, H+/H2O 2.31 Buettner, 1993
RO•, H+/ROH 1.60 Buettner, 1993
HOO•, H+/H2O2 1.06 Buettner, 1993
ROO•, H+/H2O2 1.00 Buettner, 1993
Trp•, H+/Trp 1.05 DeFillipis et al., 1989
Tyr-O•, H+/Tyr-OH 0.94 DeFillipis et al., 1989
ONOOH, H+ /•NO2, H2O 1.40 Koppenol et al., 1992
ONOOH, H+ /NO2−, H2O 1.20 Koppenol et al., 1992
HOCl, H+/Cl−, H2O 1.48 Vanýsek, 2011
HOBr, H+/Br−, H2O 1.33 Vanýsek, 2011
HOSCN, H+/SCN−, H2O 0.56 Arnhold et al., 2006
E° = 0.5V – reduction potential of the valence band for SWCNTs (Gratzel, 2001; Choi et al., 2002).
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Table 3
X-Ray Photoelectron Spectroscopy (XPS) characterization of GO samples. Carbon/oxygen content (calculated 
from survey spectra) and relative concentrations of functional groups (calculated from hi-res C1s spectra) in 
graphene oxide samples
Control + H2O2 + cyt c
+ H2O2
C:O 1.72 2.34 1.52
C−O (%) 18.19 17.20 28.05
C=O (%) 0.23 0 0.01
O−C=O (%) 1.40 1.72 0.15
C−C (%) 80.17 81.07 71.79
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